In Vitro Selection and Characterization of Human Immunodeficiency Virus Type 1 Variants with Increased Resistance to ABT-378, a Novel Protease Inhibitor

ABT-378, a new human immunodeficiency virus type 1 (HIV-1) protease inhibitor which is significantly more active than ritonavir in cell culture, is currently under investigation for the treatment of AIDS. Development of viral resistance to ABT-378 in vitro was studied by serial passage of HIV-1 (pNL...

Description complète

Détails bibliographiques

Publié dans:	J Virol
Auteurs principaux:	Carrillo, Alejandro, Stewart, Kent D., Sham, Hing L., Norbeck, Daniel W., Kohlbrenner, William E., Leonard, John M., Kempf, Dale J., Molla, Akhteruzzaman
Format:	Artigo
Langue:	Inglês
Publié:	American Society for Microbiology (ASM) 1998
Sujets:	Animal Viruses
Accès en ligne:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC109995/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/9696850/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/jvi.72.9.7532-7541.1998
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!